FullCircle Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.63M Buy
1,801
+416
+30% +$310K 0.58% 48
2025
Q2
$1.07M Buy
1,385
+151
+12% +$117K 0.4% 86
2025
Q1
$1.08M Buy
1,234
+75
+6% +$62.4K 0.45% 73
2024
Q4
$1.01M Buy
+1,159
New +$960K 0.41% 77

Other funds holding LLY

FullCircle Wealth's LLY Position: Q3 2025 in Review

FullCircle Wealth increased its Eli Lilly (LLY) stake by 30% in Q3 2025, buying an estimated $310K and bringing the position to 1,801 shares worth $1.63M. The position accounts for 0.58% of the portfolio, ranked #48.

FullCircle Wealth first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • FullCircle Wealth held 1,801 shares of Eli Lilly worth $1.63M as of Q3 2025.
  • FullCircle Wealth bought 416 Eli Lilly shares in Q3 2025, an estimated $310K.
  • Eli Lilly made up 0.58% of FullCircle Wealth's portfolio in Q3 2025, its #48 holding.
  • FullCircle Wealth first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on FullCircle Wealth's 13F filing for Q3 2025, filed 5 Nov 2025.